Emerging Infectious Diseases

Emerging Infectious Diseases (Emerg. Infect. Dis.) is an infectious disease journal published by the United States Centers for Disease Control and Prevention. Founded in 1995 and marking its thirtieth year in 2025, it concentrates on the detection, surveillance and control of emerging and re-emerging infections, is an online-only monthly free to read in full, and had a 2026 impact factor of 7.9.《新发传染病》（Emerging Infectious Diseases''''，缩写 Emerg. Infect. Dis.''）是美国疾病控制与预防中心出版的传染病刊物，1995 年创刊，2025 年迎来创刊三十周年。该刊以新发与再发传染病的监测、发现与防控为主，为纯在线月刊并对全文免费开放，二〇二六年影响因子为 7.9。

Scope

The journal's editorial stance is that a paper must concern the emergence or re-emergence of disease: however fine the pathogen work, it has to show what it means for identifying, surveilling or controlling an infection. Coverage runs from pathogen discovery to public health policy and concentrates on:本刊的取稿立场是「围绕疾病的新出现与再出现」：一篇论文不论病原学工作多么精细，都要说明它对识别、监测或控制某一传染病的实际意义。收文覆盖从病原发现到公共卫生政策的链条，重点包括：

• Surveillance and pathogen discovery: identification and characterisation of new pathogens, surveillance systems and early warning, establishment of laboratory diagnostics, and genomic epidemiology.监测与新病原发现： 新发病原的识别与鉴定、监测体系与预警、实验室诊断方法的建立、基因组流行病学。

• Human and animal health: zoonotic disease, research under the One Health framework, vector and host ecology, and mechanisms of cross-species transmission.人与动物健康交叉： 动物源性疾病、同一健康框架下的研究、媒介与宿主生态、跨种传播机制。

• Antimicrobial resistance: surveillance of resistant organisms and resistance genes, resistance mechanisms, epidemiology and control of resistant infections, and antimicrobial stewardship.抗菌药物耐药： 耐药菌与耐药基因的监测、耐药机制、耐药感染的流行与防控、抗菌药物合理使用。

• Transmission and environment: waterborne and foodborne disease, vector-borne disease, health-care-associated infection, and environmental reservoirs and exposure.传播途径与环境： 水源性与食源性疾病、媒介传播疾病、医疗机构相关感染、环境储库与暴露。

• Epidemiology and laboratory methods: outbreak investigation, case-control and cohort studies, molecular typing and source tracing, and laboratory methodology.流行病学与实验室方法： 暴发调查、病例对照与队列研究、分子分型与溯源、实验室检测方法学。

• Policy and social science: burden of disease and economic evaluation, assessment of public health policy, risk communication and behaviour, and health system response.政策与社会科学： 疾病负担与经济评价、公共卫生政策评估、风险沟通与行为、卫生系统应对。

Full text is in the public domain and free to read, with no article processing charge, and the journal is a DOAJ member. The publisher reports more than two thousand submissions a year and an acceptance rate of about 23.7 per cent本刊全文归入公有领域并免费开放，不收取文章处理费，为（DOAJ）会员；出版方公布年投稿逾两千件、录用比例约百分之二十三点七；投稿到发表的周期官方未公布。 the time from submission to publication is not published.^[1]

History

• Founding (1995): the journal was founded in 1995 under its present name with no predecessor title. The stated rationale is to promote the recognition of emerging and re-emerging infections worldwide and to understand the factors in disease emergence so as to prevent and eliminate them创刊（1995年）： 1995 年创刊，创刊即使用现名，无前身刊名。创刊动因按官方表述为促进识别全球新发与再发传染病、理解疾病出现的因素并将其用于预防与消除；创办人未单独公布。2025 年为本刊创刊三十周年。 no individual founder is named. 2025 marked the thirtieth year.^[1]

• Publishing format: the journal became monthly in 2002, introduced online submission and review in 2003, and ceased print in January 2020 to become an online-only monthly.出版形态沿革： 2002 年起改为月刊；2003 年启用在线投稿与审稿系统；2020 年 1 月起停止印刷版，转为纯在线月刊。

• Scale and access: by 2025 the journal had published more than 13,500 articles. Full text is open and free of article processing charges, an arrangement unusual among infectious disease journals and one that makes the content widely used by public health agencies in developing countries.体量与可及性： 2025 年本刊累计发文逾一万三千五百篇；全文开放且无文章处理费，这一模式在传染病刊物中较为特殊，也使其内容被发展中国家公共卫生机构广泛使用。

• Metrics and indexing: the publisher reports an impact factor of 6.6 for 2025 and 7.9 for 2026 and a CiteScore of 9.5 for 2025. The journal is archived in PubMed and PMC and indexed in DOAJ and Scopus指标与收录： 出版方公布 2025 年影响因子 6.6、2026 年影响因子 7.9、2025 年引用分数 9.5；本刊被 PubMed 与 PMC 存档、DOAJ 与 Scopus 收录，科学引文索引扩展版一项出版方未明示。 coverage by the Science Citation Index Expanded is not stated by the publisher.^[2]

Editors

The editors are staff of the Centers for Disease Control and Prevention and there have been only three in thirty years, an unusually stable succession for a government title. The present editor was previously deputy editor and took up the post at the end of November 2025.本刊主编由美国疾病控制与预防中心人员担任，三十年间仅三任，是政府出版刊物中更替最稳定的一种；现任主编此前任副主编，2025 年 11 月底接任。^[2]

• Present editor-in-chief: Matthew J. Kuehnert of the Centers for Disease Control and Prevention took up the post at the end of November 2025, having been deputy editor since 2021.现任主编： （Matthew J. Kuehnert）供职于美国疾病控制与预防中心，2025 年 11 月底接任，此前自 2021 年起任副主编。

• Past editors: the founding editor was Joseph McDade, serving from 1995 to 2001历任主编： 首任主编为（Joseph McDade），1995 年至 2001 年在任；（D. Peter Drotman）2001 年至 2025 年在任，现为荣休主编；管理编辑另有三任，依次为（Polyxeni Potter）1995 年至 2014 年、（Byron Breedlove）2014 年至 2025 年、（Lesli Mitchell）2025 年起。 D. Peter Drotman served from 2001 to 2025 and is now editor emeritus. There have been three managing editors: Polyxeni Potter from 1995 to 2014, Byron Breedlove from 2014 to 2025 and Lesli Mitchell from 2025.

• Role in the field: as the journal of a government public health agency, it is often the first channel for information during outbreaks of emerging infections, and its reports are cited directly by the World Health Organization and by national disease control agencies. Its cover image feature is also a distinctive element.学科角色： 作为政府公共卫生机构的刊物，本刊在新发传染病暴发期间常成为疫情信息的首发渠道，其报告被世界卫生组织与各国疾控机构直接引用；其封面图像栏目亦为其特色之一。